- Piggy
Banks & Crystal Ball
- Tech-Tracks
- Tambang
Batubara Bukit Asam (PTBA IJ) | Company Update
- Axiata
Group (AXIATA MK) | Results Review
- Barakah
Offshore Petroleum (BARAKAH MK) | Company Update
- CIMB
Group Holdings (CIMB MK) | Company Update
- Maxis
Bhd (MAXIS MK) | Results Review
- MISC
Bhd (MISC MK) | Results Review
- Singapore
Airlines (SIA SP) | Results Review
- Singapore
Offshore & Marine | UNDERWEIGHT
- Bumrungrad
Hospital (BH TB) | Results Preview
|
Piggy Banks & Crystal Ball
|
Regional Banks
|
Regional Banks Bi-weekly No. 7
|
- Net
rating upgrades for China banks. We expect more earnings and
TP upgrades after the recent cut in RRR given this should help
improve loan growth, NIM and asset quality of banks. Our top
BUY is Bank of China (3988 HK) given it will be a key
beneficiary of overseas expansion of mainland companies.
- More
bearish earnings outlook for HK banks. This is especially for
the coming 2014 results of both HSBC and SCB. Besides, we
believe market has not yet factored in impairment charge of
HKD2.1b for Hang Seng Bank�s
(HSB) holding of shares of Industrial Bank. Our top SELL is
HSB (11 HK) as it needs to moderate loan growth and cut DPS to
revive its fully-loaded CET1 CAR to 13% before 2018.
- Long
AFG; Funded by China Minsheng Bank. Based on our
"long-short position analysis", we see increasing
buying interest in AFG by long-only funds. We also see more
short-selling positions for CMSB by hedge funds with stable
stock borrow utilization rate.
- Fundamentals
support this trade. We believe AFG will benefit from its niche
in SME businesses, high CASA ratio and strong capitalization.
Meanwhile, we have concerns about EPS and ROE dilution from
planned capital replenishment of CMSB as well as low provision
coverage for its loan portfolio.
|
Tech-Tracks
|
Regional Quants
|
Buoyant markets may re-test
resistances
|
- US
markets gyrated nervously at lofty levels from poorer
corporate results and benign job data. However, a good
reversal in crude oil�s
downtrend lifted equity market sentiment in early February.
- Regionally,
the undulating undertones improved despite US Dollar strength
against emerging ASEAN currencies and the Euro. A sign that
funds are placing their bets in Asia ex Japan is that most
indices have risen over the last fortnight (with the exception
of Vietnam).
- Top
BUYs: ComfortDelGro Corporation Limited (CD SP), Fuguiniao Co
Ltd (1819 HK), Japan Vietnam Medical Instrument JSC (JVC VN),
Fortune Parts Industry PCL (FPI TB), PT Pembangunan Perumahan
Persero Tbk (PTPP IJ), Karex Berhad (KAREX MK) and First
Philippine Holdings Corporation (FPH PM).
|
Tambang Batubara Bukit Asam (PTBA
IJ)
|
Lower TP
|
Share Price: IDR11,375 | Target
Price: IDR13,400 (+18%) | MCap (USD): 2.1B | ADTV (USD): 2M
|
- Maintain
BUY but cut DCF TP to IDR13,400 from IDR15,000 for lower
long-term railway volume.
- PTKA
missed railway-volume target again. Rajawali project may be
delayed. But every 1% increase in PLN�s ASPs could lift 2015F EPS
by 4.4%.
- 3.1x
P/BV at 14% discount to 12-year mean.
|
Axiata Group (AXIATA MK)
|
XL ahead on better margins
|
Share Price: MYR7.17 | Target
Price: MYR7.80 (+9%) | MCap (USD): 17.3B | ADTV (USD): 16M
|
- XL�s FY14 EBITDA was in line
with ours and consensus forecasts; net profit was ahead of
expectations.
- Margins
expanded QoQ as major cost items trended down, aided by
provision reversal and finance lease income.
- XL�s FY14 earnings are
distorted by the Axis acquisition; our BUY rating and MYR7.80
TP for Axiata are unchanged.
|
Barakah Offshore Petroleum
(BARAKAH MK)
|
Clinches PCSB job worth MYR110m
|
Share Price: MYR0.97 | Target
Price: MYR1.15 (+19%) | MCap (USD): 207M | ADTV (USD): 1M
|
- This
is for a pig trap system works, on 3+1 year contract.
- Targets
to replenish MYR600m contracts for 2015.
- Reiterate
Trading Buy and MYR1.15 TP (10x 2016 PER).
|
CIMB Group Holdings (CIMB MK)
|
T18 unveiled
|
Share Price: MYR5.80 | Target
Price: MYR5.70 (-2%) | MCap (USD): 13.8B | ADTV (USD): 15M
|
- Ambitious
goals include CIR < 50% and ROAE >15% by FY18 from cost
savings and business acceleration.
- More
specifics required to convince that lofty targets can be
achieved.
- HOLD
maintained, TP of MYR5.70 on FY15 P/BV peg of 1.2x.
|
Maxis Bhd (MAXIS MK)
|
Positive revenue momentum
|
Share Price: MYR6.99 | Target
Price: MYR7.40 (+6%) | MCap (USD): 14.8B | ADTV (USD): 8M
|
- 2014
net profit below ours/consensus expectations owing to higher
depreciation; EBITDA was in line.
- Encouragingly,
revenue trended up sequentially for both the prepaid and
postpaid segments, albeit aided by seasonality.
- Slight
earnings cuts on higher depreciation; BUY rating and MYR7.40
TP unchanged.
|
MISC Bhd (MISC MK)
|
Growth catalyst nears
|
Share Price: MYR7.74 | Target
Price: MYR8.70 (+12%) | MCap (USD): 9.7B | ADTV (USD): 5M
|
- Strong
4Q14; expect better 2015 on performance by Offshore, Petroleum
and Chemical divisions.
- Impetus
from LNG contract renewals and LNG newbuilds.
- Maintain
BUY, raised SOP-based TP to MYR8.70 (+9%).
|
Singapore Airlines (SIA SP)
|
3QFY15 below, fuel-hedge spoiler
|
Share Price: SGD12.13 | Target
Price: SGD12.00 (-1%) | MCap (USD): 10.6B | ADTV (USD): 14M
|
- Transfer
of coverage. 3QFY3/15 core net income of SGD146.4m slightly
below due to higher-priced fuel hedges.
- Parent
airline continued to struggle. Subsidiary airlines - Silkair,
SIA Cargo, Tigerair - performed well.
- EPS,
BUY & SGD12 SOTP TP unchanged, pending briefing today.
|
Singapore Offshore & Marine
|
Sector Update
|
Sete Brasil woes may spill over
|
- Brazil
national bank, BNDES, once again postponed USD3.2b loan to
Sete Brasil.
- Ex-Petrobras
executive alleged shipyard contractors paid bribes to secure
rig-building contracts.
- Keppel
Corp & SembMarine unlikely involved in bribery but may
have to write down order books in worst case scenario that
Sete Brasil could not pay.
|
Bumrungrad Hospital (BH TB)
|
Expect strong 4Q; Valuations
stretched
|
Share Price: THB158.00 | Target
Price: THB130.00 (-18%) | MCap (USD): 3.5B | ADTV (USD): 3M
|
- Maintain
HOLD with DCF-based TP of THB130, implying 35x PER, 7x P/BV,
and 1.5x PEG for FY15F. We expect greater competition.
Valuations stretched, switch to BGH (TP THB23)
- Expect
hospital revenue to increase 10% YoY as IPD and OPD revenue
should rise 7% and 9%. Patient traffic could grow 13% with 5%
rise in prices.
- Estimate
net profit of THB700 in 4Q14, -9% QoQ on seasonal weakness
while +12% YoY due to continuous volume growth, return of int�l patients, and EBITDA
margin expansion.
|
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.